KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Palvella Therapeutics (PVLA) Shares Outstanding (Weighted Average) (2016 - 2026)

Palvella Therapeutics has reported Shares Outstanding (Weighted Average) over the past 10 years, most recently at $74.2 million for Q4 2022.

  • Quarterly Shares Outstanding (Weighted Average) rose 14.91% to $74.2 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $74.2 million through Dec 2022, up 14.91% year-over-year, with the annual reading at $74.2 million for FY2022, 14.91% up from the prior year.
  • Shares Outstanding (Weighted Average) was $74.2 million for Q4 2022 at Palvella Therapeutics, roughly flat from $74.4 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $74.4 million in Q3 2022 and troughed at $49.2 million in Q2 2019.
  • The 5-year median for Shares Outstanding (Weighted Average) is $54.2 million (2018), against an average of $58.2 million.
  • Year-over-year, Shares Outstanding (Weighted Average) decreased 8.85% in 2019 and then soared 30.93% in 2022.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $53.1 million in 2018, then dropped by 4.63% to $50.6 million in 2019, then increased by 7.62% to $54.5 million in 2020, then grew by 18.48% to $64.5 million in 2021, then grew by 14.91% to $74.2 million in 2022.
  • Per Business Quant, the three most recent readings for PVLA's Shares Outstanding (Weighted Average) are $74.2 million (Q4 2022), $74.4 million (Q3 2022), and $73.9 million (Q2 2022).